Shan Guogen, Ma Changxing, Hutson Alan D, Wilding Gregory E
Department of Environmental and Occupational Health, Epidemiology and Biostatistics Program, University of Nevada Las Vegas, Las Vegas, Nevada 89154, USA.
J Biopharm Stat. 2013;23(5):1081-90. doi: 10.1080/10543406.2013.813525.
In areas such as oncology, two-stage designs are often preferred as compared to one-stage designs due to the ability to stop the trial early when faced with evidence of lack of sufficient efficacy and the associated sample size savings. We present exact two-stage designs based on Barnard's exact test for differences in proportions and compare the designs to those proposed by Kepner ( 2010 ) and Jung ( 2010 ). In addition, we present tables of decision rules under a variety of assumed realities for use in trial planning. The procedure is recommended for use due to the substantial sample size savings experienced.
在肿瘤学等领域,与单阶段设计相比,两阶段设计通常更受青睐,因为当面对疗效不足的证据时能够提前终止试验,并且可以节省相关样本量。我们基于Barnard精确检验比例差异提出了精确的两阶段设计,并将这些设计与Kepner(2010年)和Jung(2010年)提出的设计进行比较。此外,我们给出了在各种假设现实情况下用于试验规划的决策规则表。由于能大幅节省样本量,推荐使用该程序。